Clinical Development


Clinical Development

Vocal Biomarkers Pipeline

Voice analysis has been linked to a number of health disorders including Parkinson’s disease, obstructive sleep apnea (OSA) and autism spectrum disorder (ASD).

Our passion is to bring voice, AI and digital health together to manage and triage diseases.


Research Article

This study describes for the first time how voice analysis can assist in risk stratification of patients with congestive heart failure with respect to overall survival and/or hospitalizations.

We found a vocal biomarker that correlates with hospitalization and mortality of chronic patients.

This study supports the hypothesis that vocal biomarkers might assist in identification of high-risk subjects in areas where access to services such as physical examination, blood tests, and cardiovascular imaging are limited.


Vocal Biomarker is Associated with Hospitalization and
Mortality Among Heart Failure Patients Journal of the American Heart Association

Non-invasive vocal biomarker
is associated with
pulmonary hypertension

Noninvasive vocal biomarker is associated with adverse outcome among CHF patients, suggesting a possible role for voice analysis in telemedicine and CHF patient care.

Non-invasive vocal biomarker is associated with
pulmonary hypertensionPLOS ONE Research Article

Clinical Development

We are constantly involved in exploring the potential of voice and AI in the field of healthcare. We are in the process of following up on completed clinical research with commercial and clinical projects.